An alarming public health crisis is on the horizon: the rise of superbugs, or bacterial infections that are resistant to antibiotic treatment. Antibiotics have been essential to our society since their discovery in 1928. It’s estimated that penicillin, the first antibiotic, has saved up to 200 million lives. In addition to fighting common illnesses, antibiotics have been key to developing many modern surgical procedures, as they help surgical wounds resist bacterial infection.
Nano Chairman and CEO Steve Papermaster and TechCrunch Editor-at-Large Mike Butcher recently sat down together in London to discuss Nano Vision’s mission, platform development and initial cure acceleration targets. View the video or read the full transcript below.
Science is reserved for people in white lab coats with expensive degrees and sophisticated equipment, right? Wrong. Citizen scientists are ordinary people who participate in science through data collection, scientific study participation or even just support of scientific projects or endeavors. Citizen scientists play a critical role in the healthcare and research worlds and should be empowered to contribute however they can. Continue reading
Data is one of our most valuable commodities – it gives us critical information about our world and holds the key to cures for diseases. It’s also very expensive to create.
Companies, universities and other institutions invest enormous amounts of time and money in research programs or clinical trials to produce important data with the hope that it will have an impact on health through the creation of new treatments or cures. Unfortunately, after having invested substantially in research and trials , these stakeholders are not incentivized to share this data with others. Continue reading
AUSTIN, TX, USA – November 21, 2017 – Nano, an Austin-based molecular data company, today announced that it is developing a chip using intellectual property (IP) from Arm, the world’s leading semiconductor IP company. The technology will help redefine how global health challenges – from superbugs to infectious diseases, and cancer are conquered.
The pioneering system-on-chip (SoC) will yield highly-secure molecular data that can be used in the recognition and analysis of health threats caused by pathogens and other living organisms. Combined with the company’s scientific technology platform, the chip leverages advances in nanotechnology, optics, artificial intelligence (AI), blockchain authentication, and edge computing to access and analyze molecular-level data in real time.
“We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology.”
Rene Haas, Executive Vice President and President of IPG, Arm
“In partnership with Arm, we’re tackling the vast frontier of molecular data to unlock the unlimited potential of this universe,” said Steve Papermaster, Chairman and CEO of Nano Global. “The data our technology can acquire and process will enable us to create a safer and healthier world.”
“We believe the technology Nano Global is delivering will be an important step forward in the collective pursuit of care that improves lives through the application of technology,” said Rene Haas, executive vice president and president of IPG, Arm. “By collaborating with Nano Global, Arm is taking an active role in developing and deploying the technologies that will move us one step closer to solving complex health challenges.”
Additionally, Nano Global will be partnering with several leading institutions, including Baylor College of Medicine and National University of Singapore, on broad research initiatives in clinical, laboratory, and population health environments to accelerate data collection, analysis, and product development.
The initial development of the chip is in process with first delivery expected by 2020. The company is already adding new partners to the platform.